ZOLL Itamar
Home Sleep Apnea Test and Digital Health Company.
Home Sleep Apnea Test and Digital Health Company.
ZOLL Itamar is a healthcare startup that has been revolutionizing the integration of Sleep Apnea management into the cardiac patient care pathway since its founding in 1997. Based in the United States, the company has established itself as a pioneer in home sleep testing, offering innovative solutions for patients and healthcare professionals. Its most recent $70.00M Post-IPO Secondary investment at 07 February 2021 was secured from Cybele Holdings. ZOLL Itamar's commitment to digital health and medtech is evident in its impactful home sleep apnea test program. This noteworthy investment testifies to the company's potential for significant growth and its attractiveness to discerning investors seeking opportunities in the sleep and cardiology sectors. For more information, visit the company's website and disclaimer at https://bit.ly/3dZfGPU. With a strong focus on innovation and its track record as an industry leader, ZOLL Itamar is poised for continued success in the evolving landscape of telehealth and medical technology.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Post-IPO Secondary | $70.00M | 1 | Cybele Holdings | 07 Feb 2021 |
| Post-IPO Secondary | $45.00M | - | 02 Feb 2020 | |
| Post-IPO Equity | $8.00M | 4 |
|
18 Jan 2019 |
| Venture Round | ILS22.00M | 1 | Cybele Holdings | 01 Mar 2018 |
| Venture Round | ILS18.60M | 1 | Cybele Holdings | 01 Dec 2015 |
No recent news or press coverage available for ZOLL Itamar.
We care about your data, and we'd love to use cookies make your experience better.
